Variant report
Variant | nsv8068 |
---|---|
Chromosome Location | chr7:19618846-19682421 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:19161315..19162333-chr7:19661177..19662063,3 | MCF-7 | breast: | |
2 | chr2:135445671..135446510-chr7:19643090..19643903,2 | MCF-7 | breast: | |
3 | chr7:19641533..19643172-chr7:19643344..19645387,2 | K562 | blood: | |
4 | chr7:19641533..19643172-chr7:19643344..19645387,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560961466 | chr7:19619610-19619611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386710962 | chr7:19619618-19619619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371812325 | chr7:19619629-19619630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7786622 | chr7:19619640-19619641 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs7805790 | chr7:19619643-19619644 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs533556357 | chr7:19619660-19619661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185413063 | chr7:19619680-19619681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10244939 | chr7:19619689-19619690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542158649 | chr7:19619736-19619737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190662989 | chr7:19619761-19619762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545571049 | chr7:19619791-19619792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528011956 | chr7:19619864-19619865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4626493 | chr7:19619868-19619869 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs567659073 | chr7:19619878-19619879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537904007 | chr7:19619916-19619917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2390142 | chr7:19619922-19619923 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs369642244 | chr7:19619938-19619939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73681810 | chr7:19619961-19619962 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs372331874 | chr7:19619963-19619964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141270677 | chr7:19619966-19619967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2390143 | chr7:19619995-19619996 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs542299067 | chr7:19623021-19623022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183835253 | chr7:19623064-19623065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10273311 | chr7:19623068-19623069 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs566825259 | chr7:19623069-19623070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10228147 | chr7:19623091-19623092 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs189857825 | chr7:19623095-19623096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550097106 | chr7:19623105-19623106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555223490 | chr7:19623143-19623144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114706902 | chr7:19623153-19623154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369273931 | chr7:19623175-19623176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537683105 | chr7:19623221-19623222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575848317 | chr7:19623267-19623268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4721793 | chr7:19623268-19623269 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs377653691 | chr7:19623274-19623275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555030399 | chr7:19623294-19623295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544575503 | chr7:19623351-19623352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4721794 | chr7:19623358-19623359 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs540223301 | chr7:19623367-19623368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542713410 | chr7:19623386-19623387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560868658 | chr7:19623449-19623450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs28617207 | chr7:19623465-19623466 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs145659999 | chr7:19623477-19623478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373126219 | chr7:19623495-19623496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533691396 | chr7:19623499-19623500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551757383 | chr7:19623505-19623506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116356237 | chr7:19623523-19623524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527729848 | chr7:19623562-19623563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1074858 | chr7:19623571-19623572 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs568681769 | chr7:19623636-19623637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:19619600-19620000 | Enhancers | HSMM | muscle |
2 | chr7:19623000-19624000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:19625600-19626200 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr7:19634800-19635600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr7:19635200-19635800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr7:19641600-19642800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
7 | chr7:19641600-19643000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr7:19642400-19642800 | ZNF genes & repeats | Duodenum Smooth Muscle | Duodenum |
9 | chr7:19643000-19645000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr7:19645000-19645400 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr7:19652600-19653400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr7:19657600-19661800 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr7:19658400-19661000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr7:19658400-19661800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr7:19658600-19659000 | Enhancers | HSMM | muscle |
16 | chr7:19661000-19662800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr7:19661800-19663400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr7:19662800-19663400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr7:19663400-19663600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr7:19673200-19673600 | Enhancers | H9 Cell Line | embryonic stem cell |
21 | chr7:19673200-19673600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |